AbbVie Inc.
ABBVNYSE#70 by turnover$285.64+0.16%Market closed · As of Oct 24, 05:00 AM (KST)
Key filings
All filings on SEC ›Earnings, material events (8-K), quarterly and annual reports, ownership reports
- 2026-10-158-KMaterial event report · Officer/director changeSource ↗
- 2026-10-058-KMaterial event report · Earnings releaseSource ↗
- 2026-09-038-KMaterial event report · Reg FD disclosureSource ↗
- 2026-08-188-KMaterial event report · Other eventsSource ↗
- 2026-08-058-KMaterial event report · Other eventsSource ↗
- 2026-08-0310-QQuarterly reportSource ↗
- 2026-07-318-KMaterial event report · Earnings releaseSource ↗
- 2026-07-068-KMaterial event report · Earnings releaseSource ↗
- 2026-06-228-KMaterial event report · Reg FD disclosureSource ↗
- 2026-05-128-KMaterial event report · Shareholder vote resultsSource ↗
- 2026-05-0810-QQuarterly reportSource ↗
- 2026-04-29SCHEDULE 13G5%+ ownership (passive)Source ↗
- 2026-04-298-KMaterial event report · Earnings releaseSource ↗
- 2026-04-038-KMaterial event report · Earnings releaseSource ↗
- 2026-03-26SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.
Insider trades & planned sales
Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)
- 2026-10-233Initial insider ownershipSource ↗
- 2026-10-024Insider transactionSource ↗
- 2026-10-024Insider transactionSource ↗
- 2026-08-184Insider transactionSource ↗
- 2026-08-14144Notice of proposed saleSource ↗
- 2026-07-024Insider transactionSource ↗
- 2026-07-024Insider transactionSource ↗
- 2026-05-26144Notice of proposed saleSource ↗
- 2026-05-124Insider transactionSource ↗
- 2026-05-124Insider transactionSource ↗